The American Lung Association Lung Cancer Discovery Award supports highly meritorious research projects with the potential to significantly improve diagnostic and therapeutic strategies for lung cancer. The award seeks to drive innovation in prevention, screening, biology, and treatment of lung cancer, particularly focusing on areas such as genetic subtypes, never-smoker disease, and novel clinical approaches.
Eligibility Criteria
-
Applicants must hold a doctoral degree (PhD, MD, DO, DSc, or equivalent).
-
Must have completed a training fellowship and hold a full-time faculty or professional appointment at an academic or research institution.
-
Must be an independent, self-directed researcher with institutional support for space and resources.
-
The host institution must be a U.S.-based, nonprofit academic or research organization.
-
Applicants must be authorized to work in the United States.
-
Only one American Lung Association grant application or LOI may be submitted per annual cycle.
-
Applicants may receive this award only once.
Funding Details:
-
Amount: 100,000 USD per year (up to 200,000 USD total).
-
Duration: 2 years (July 1, 2026 – June 30, 2028).
-
Up to 75% of the total budget may be used for salary and fringe benefits.
-
Up to 30% may be used for permanent equipment purchases.
-
Indirect costs are not allowed.
-
Research must focus on innovative approaches that advance understanding and treatment of lung cancer, including EGFR-driven and other genetic forms.
Deadline:
-
Full application deadline: 1 December 2025 (11:59 PM ET).
Where to Go For Further Information: